Título: | Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity |
Autores/as: | Volz, Erik Hill, Verity McCrone, John T. Price, Anna Jorgensen, David O'Toole, Áine Southgate, Joel Johnson, Robert Jackson, Ben Nascimento, Fabricia F. Rey, Sara M. Nicholls, Samuel M. Colquhoun, Rachel M. da Silva Filipe, Ana Shepherd, James Pascall, David J. Shah, Rajiv Jesudason, Natasha Li, Kathy Jarrett, Ruth Pacchiarini, Nicole Bull, Matthew Geidelberg, Lily Siveroni, Igor Koshy, Cherian Wise, Emma Cortes, Nick Lynch, Jessica Kidd, Stephen Mori, Matilde Fairley, Derek J. Curran, Tanya McKenna, James P. Adams, Helen Fraser, Christophe Golubchik, Tanya Bonsall, David Moore, Catrin Caddy, Sarah L. Khokhar, Fahad A. Wantoch, Michelle Reynolds, Nicola Warne, Ben Maksimovic, Joshua Spellman, Karla McCluggage, Kathryn John, Michaela Beer, Robert Afifi, Safiah Morgan, Sian Marchbank, Angela Kitchen, Christine Gulliver, Huw Merrick, Ian Guest, Martyn Munn, Robert Workman, Trudy Connor, Thomas R. Fuller, William Bresner, Catherine Snell, Luke B. Charalampous, Themoula Nebbia, Gaia Batra, Rahul Edgeworth, Jonathan Robson, Samuel C. Beckett, Angela Loveson, Katie F. Aanensen, David M. Underwood, Anthony P. Yeats, Corin A. Abudahab, Khalil Taylor, Ben E.W. Menegazzo, Mirko Clark, Gemma Smith, Wendy Khakh, Manjinder Fleming, Vicki M. Lister, Michelle M. Howson-Wells, Hannah C. Berry, Louise Boswell, Tim Joseph, Amelia Willingham, Iona Bird, Paul Helmer, Thomas Fallon, Karlie Holmes, Christopher Tang, Julian Raviprakash, Veena Campbell, Sharon Sheriff, Nicola Loose, Matthew W. Holmes, Nadine Moore, Christopher Carlile, Matthew Wright, Victoria Sang, Fei Debebe, Johnny Coll, Francesc Betancor Quintana, Gilberto Jose |
Clasificación UNESCO: | 32 Ciencias médicas 320505 Enfermedades infecciosas |
Palabras clave: | COVID-19 Epidemiology Evolution Founder effect SARS-CoV-2, et al. |
Fecha de publicación: | 2021 |
Publicación seriada: | Cell |
Resumen: | Global dispersal and increasing frequency of the SARS-CoV-2 spike protein variant D614G are suggestive of a selective advantage but may also be due to a random founder effect. We investigate the hypothesis for positive selection of spike D614G in the United Kingdom using more than 25,000 whole genome SARS-CoV-2 sequences. Despite the availability of a large dataset, well represented by both spike 614 variants, not all approaches showed a conclusive signal of positive selection. Population genetic analysis indicates that 614G increases in frequency relative to 614D in a manner consistent with a selective advantage. We do not find any indication that patients infected with the spike 614G variant have higher COVID-19 mortality or clinical severity, but 614G is associated with higher viral load and younger age of patients. Significant differences in growth and size of 614G phylogenetic clusters indicate a need for continued study of this variant. |
URI: | http://hdl.handle.net/10553/122945 |
ISSN: | 0092-8674 |
DOI: | 10.1016/j.cell.2020.11.020 |
Fuente: | Cell [ISSN 0092-8674] , v. 184 (1), p. 64-75 e11 (Enero 2021) |
Colección: | Artículos
|